TY - JOUR
T1 - Primary effusion lymphoma with skin involvement
AU - Inoue, S.
AU - Miyamoto, T.
AU - Yoshino, T.
AU - Yamadori, I.
AU - Hagari, Y.
AU - Yamamoto, O.
PY - 2006/11
Y1 - 2006/11
N2 - Primary effusion lymphoma (PEL) was once defined as a body cavity-based lymphoma without identifiable contiguous tumour mass, but is now recognised as an independent clinicopathological entity. The case of a 67-year-old Japanese woman with PEL is reported, in which the clinical findings showed a pericardial effusion and multiple erythema on the hypogastrium and inguinal region. The histopathological findings showed a diffuse infiltration of large neoplastic B cells from the dermis to the subcutis. After the disappearance of pericardial effusion without any treatment, she received several rounds of chemotherapy to resolve the skin eruption, but she finally died from multiple organ failure. No tumour mass was observed during the course of her disease.
AB - Primary effusion lymphoma (PEL) was once defined as a body cavity-based lymphoma without identifiable contiguous tumour mass, but is now recognised as an independent clinicopathological entity. The case of a 67-year-old Japanese woman with PEL is reported, in which the clinical findings showed a pericardial effusion and multiple erythema on the hypogastrium and inguinal region. The histopathological findings showed a diffuse infiltration of large neoplastic B cells from the dermis to the subcutis. After the disappearance of pericardial effusion without any treatment, she received several rounds of chemotherapy to resolve the skin eruption, but she finally died from multiple organ failure. No tumour mass was observed during the course of her disease.
UR - http://www.scopus.com/inward/record.url?scp=33751212761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33751212761&partnerID=8YFLogxK
U2 - 10.1136/jcp.2005.031807
DO - 10.1136/jcp.2005.031807
M3 - Article
C2 - 17071811
AN - SCOPUS:33751212761
SN - 0021-9746
VL - 59
SP - 1221
EP - 1222
JO - Molecular pathology : MP
JF - Molecular pathology : MP
IS - 11
ER -